China Medipharm Insights - December 1999

 

USD 1,000

* Required Fields

USD 1,000

PAY BY INVOICE

Be the first to review this product

Table of Contents

China Medipharm Insights - December 1999, China Medipharm InsightProduct AnalysisThe Production And Sales of alpha-Interferon in ChinaSubtypes AnalysisMarket TrendsMarket AnalysisChinese Diabetes Medications Market Is Growing at a Pace Greater Than 20 percent AnnuallyMarket Growth and OpportunitiesCompetitive AnalysisCompany ProfileShenzhen Wanhe Collaborates With HMRLargest Pharmaceutical Joint Venture in HunanXinhua Exports UpMSD Provided Bronchitis-Emphysema Research FundLukang Group Leaps ForwardThree Companies to Jointly Build a Doxycycline Production Line Largest Asian Citric Acid Production Base EstablishedNorth China Pharma Improves its Sales NetworkGuilin Huanuowei Gene Pharma EstablishedShengang Jinan University Biotech EstablishedRongchang Builds Modern Bioengineering LaboratoryShanghai Zhongke Shenglongda Biotechnology EstablishedShanghai High Purity Bio-Materials Company FormedNeptunus Bioengineering Acquires Neptunus PharmaceuticalTianjin Pharma Group Embraces Tianjin Institute Dongya Pharma Sees Fast GrowthChina Medicine Group to Distribute EpristerideHebei Pharma Exhibits Large Margin Growth Huashidan Passes Gmp CertificationXianchen Expansion ProjectProduct NewsFrench Tigra Pill Lands in ChinaP&U Launches Smoking Cessation Products in ChinaRoche Taishan Starts Vitamin A Production rh-GH Produced in AnhuiJ&J Launch Tylenol SuspensionsGemzar Marketed in ChinaSilkworm Produces Cancer TherapyProstatic Cancer Detection KitLivzon’s Interferon MarketedDomestic Cefaclor DevelopedPharmaceutical Market An Analysis of the Chinese Penicillin Industry Another Vitamin C War Pending For Chinese ManufacturersAnother Vitamin C War Pending For Chinese ManufacturersAnalysis of Health Product Exports in First Five MonthsAnalysis of Health Product Exports in First Five MonthsWestern Drugs Exports Have Steadily Grown While TCM Exports Continued to Drop and Total Export Value Has Increased SlightlyExport to Tier II Markets Expanded Dramatically More Products With High Added ValueNews in BriefSDPC Issues New Regulations on Drug PricingSDA Issues New Regulations on Drug Contract ManufacturingNew GLP & GCP Standards ReleasedSDA Gears Up Regulation on Drug Research OrganizationsSDA Re-Certified Drug Clinical Research Centers Prescription & OTC Drug System Trial in Three CitiesQingdao Keeps Medical Expenditure DownMedical Expenditures Down in GuangzhouBanks Actively Participate in Medical Insurance in Guangzhou Ningxia Pharmaceutical Economy Maintains GrowthZhejiang Pharmaceutical Industry Shows Upward TrendDrugstore in Jiangyin Operates Under Medical Insurance China Life Insurance Designated 11 Hospitals in Beijing Fujian Sets Rules to Prevent Repetition in Drug BusinessChinese Provinces Lower Drug Prices Jiangsu Cuts Drug PricesHubei Lowers Drug Prices AgainZhejiang Adopts Drug Prices Registration and Publication SystemNumber of Hiv Carriers Increasing in China1999 Key High-Tech Enterprises Defined in ChinaThe Top Ten Causes Of Death in Chinese ResidentsThe Incidence of Child Diabetes Increases in ChinaHepatitis B Virus Antigen Mutant DiscoveredBiomedicine Industrial Park to be Established In Anhui1999 China Pharmaceutics Prizes 1999 SETC Science & Technology Progress Prize WinnersDrug Quality Improved in ShanghaiQ3 Drug Quality Inspection ConcludedExcellent Ophthalmologists Award SustainedVenture Fund Established to Support Drug Development Wuhan Drug Administration Commences OperationResearch On Major Chinese Ethnic Groups Completed




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.